Route of delivery modulates the efficacy of mesenchymal stem cell therapy for myocardial infarction: a meta-analysis of preclinical studies and clinical trials

Circulation Research

Volumn 120, Issue 7, 2017, Pages 1139-1150

  Kanelidis, Anthony J ^a   Premer, Courtney ^a   Lopez, Juan ^b   Balkan, Wayne ^a   Hare, Joshua M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

cell and tissue based therapy; heart failure; mesenchymal stem cell transplantation; meta analysis; myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DIRECT INTRAMYOCARDIAL INJECTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFUSION THERAPY; INJECTION SITE; INTRACORONARY DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC CARDIOMYOPATHY; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS; NONHUMAN; PIG; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THERAPY EFFECT; TRANSENDOCARDIAL STEM CELL INJECTION; ADVERSE EFFECTS; ANIMAL; CLINICAL TRIAL (TOPIC); INJECTION; MOUSE; MYOCARDIAL INFARCTION; PROCEDURES; RAT;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; INJECTIONS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MYOCARDIAL INFARCTION; RATS; SWINE;

EID: 85008350885     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309819     Document Type: Article

References (35)

1. Mozaffarian D, Benjamin EJ, Go AS, Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 2016 133 e38 e360
2. Williams AR, Hare JM, Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011 109 923 940. doi: 10.1161/CIRCRESAHA.111.243147.
3. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP, Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004 94 92 95. doi: 10.1016/j.amjcard.2004.03.034.
4. Gao LR, Pei XT, Ding QA, A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction. Int J Cardiol 2013 168 3191 3199. doi: 10.1016/j.ijcard.2013.04.112.
5. Lee JW, Lee SH, Youn YJ, Ahn MS, Kim JY, Yoo BS, Yoon J, Kwon W, Hong IS, Lee K, Kwan J, Park KS, Choi D, Jang YS, Hong MK, A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci 2014 29 23 31. doi: 10.3346/jkms.2014.29.1.23.
6. Rodrigo SF, van Ramshorst J, Hoogslag GE, Boden H, Velders MA, Cannegieter SC, Roelofs H, Al Younis I, Dibbets-Schneider P, Fibbe WE, Zwaginga JJ, Bax JJ, Schalij MJ, Beeres SL, Atsma DE, Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res 2013 6 816 825. doi: 10.1007/s12265-013-9507-7.
7. Wang X, Xi WC, Wang F, The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction. Biotechnol Lett 2014 36 2163 2168. doi: 10.1007/s10529-014-1589-z.
8. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W, A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009 54 2277 2286. doi: 10.1016/j.jacc.2009.06.055.
9. Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y, Immunobiology of mesenchymal stem cells. Cell Death Differ 2014 21 216 225. doi: 10.1038/cdd.2013.158.
10. Karantalis V, Suncion-Loescher VY, Bagno L, Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol 2015 66 1990 1999. doi: 10.1016/j.jacc.2015.08.879.
11. Hare JM, Fishman JE, Gerstenblith G, Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012 308 2369 2379. doi: 10.1001/jama.2012.25321.
12. Heldman AW, DiFede DL, Fishman JE, Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 2014 311 62 73. doi: 10.1001/jama.2013.282909.
13. Harding J, Roberts RM, Mirochnitchenko O, Large animal models for stem cell therapy. Stem Cell Res Ther 2013 4 23. doi: 10.1186/scrt171.
14. Milani-Nejad N, Janssen PM, Small and large animal models in cardiac contraction research: advantages and disadvantages. Pharmacol Ther 2014 141 235 249. doi: 10.1016/j.pharmthera.2013.10.007.
15. Elnakish MT, Hassan F, Dakhlallah D, Marsh CB, Alhaider IA, Khan M, Mesenchymal stem cells for cardiac regeneration: translation to bedside reality. Stem Cells Int 2012 2012 646038. doi: 10.1155/2012/646038.
16. Baraniak PR, McDevitt TC, Stem cell paracrine actions and tissue regeneration. Regen Med 2010 5 121 143. doi: 10.2217/rme.09.74.
17. van den Akker F, Deddens JC, Doevendans PA, Sluijter JP, Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. Biochim Biophys Acta 2013 1830 2449 2458. doi: 10.1016/j.bbagen.2012.08.026.
18. Williams AR, Suncion VY, McCall F, Guerra D, Mather J, Zambrano JP, Heldman AW, Hare JM, Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. J Am Heart Assoc 2013 2 e000140. doi: 10.1161/JAHA.113.000140.
19. Thakker R, Yang P, Mesenchymal stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med 2014 16 323. doi: 10.1007/s11936-014-0323-4.
20. Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, Wu JC, Bolli R, Perin EC, Moyé L, Simari RD, Wolf A, Hare JM, Cardiovascular Cell Therapy Research Network Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease. Stem Cells Transl Med 2016 5 186 191. doi: 10.5966/sctm.2015-0101.
21. Zwetsloot PP, Végh AM, Jansen of Lorkeers SJ, van Hout GP, Currie GL, Sena ES, Gremmels H, Buikema JW, Goumans MJ, Macleod MR, Doevendans PA, Chamuleau SA, Sluijter JP, Cardiac stem cell treatment in myocardial infarction: a systematic review and meta- analysis of preclinical studies. Circ Res 2016 118 1223 1232. doi: 10.1161/CIRCRESAHA.115.307676.
22. Karantalis V, DiFede DL, Gerstenblith G, Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res 2014 114 1302 1310. doi: 10.1161/CIRCRESAHA.114.303180.
23. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ, Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv 2002 55 392 397
24. Sheng CC, Zhou L, Hao J, Current stem cell delivery methods for myocardial repair. Biomed Res Int 2013 2013 547902. doi: 10.1155/2013/547902.
25. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM, Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005 102 11474 11479. doi: 10.1073/pnas.0504388102.
26. Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, Gutman MR, Hatzistergos KE, Oskouei BN, Zimmet JM, Young RG, Heldman AW, Lardo AC, Hare JM, Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 2008 294 H2002 H2011. doi: 10.1152/ajpheart.00762.2007.
27. Hatzistergos KE, Quevedo H, Oskouei BN, Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010 107 913 922. doi: 10.1161/CIRCRESAHA.110.222703.
28. Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, Young R, Rippy MK, Virmani R, Litt H, Wilensky RL, A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 2008 29 251 259. doi: 10.1093/eurheartj/ehm559.
29. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM, Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009 106 14022 14027. doi: 10.1073/pnas.0903201106.
30. van der Spoel TI, Gathier WA, Koudstaal S, van Slochteren F, Of Lorkeers SJ, Sluijter JP, Hoefer IE, Steendijk P, Cramer MJ, Doevendans PA, van Belle E, Chamuleau SA, Autologous mesenchymal stem cells show more benefit on systolic function compared to bone marrow mononuclear cells in a porcine model of chronic myocardial infarction. J Cardiovasc Transl Res 2015 8 393 403. doi: 10.1007/s12265-015-9643-3.
31. van der Spoel TI, Jansen of Lorkeers SJ, Agostoni P, van Belle E, Gyöngyösi M, Sluijter JP, Cramer MJ, Doevendans PA, Chamuleau SA, Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc Res 2011 91 649 658. doi: 10.1093/cvr/cvr113.
32. Kurtz A, Mesenchymal stem cell delivery routes and fate. Int J Stem Cells 2008 1 1 7
33. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD, Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004 363 783 784. doi: 10.1016/S0140-6736(04)15695-X.
34. Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, Kellner J, Zviman MM, Hatzistergos KE, Detrick B, Conte JV, McNiece I, Steenbergen C, Lardo AC, Hare JM, Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J 2009 30 2722 2732. doi: 10.1093/eurheartj/ehp265.
35. Kelkar AA, Butler J, Schelbert EB, Greene SJ, Quyyumi AA, Bonow RO, Cohen I, Gheorghiade M, Lipinski MJ, Sun W, Luger D, Epstein SE, Mechanisms contributing to the progression of ischemic and nonischemic dilated cardiomyopathy: possible modulating effects of paracrine activities of stem cells. J Am Coll Cardiol 2015 66 2038 2047. doi: 10.1016/j.jacc.2015.09.010.